Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-022388
Filing Date
2023-02-15
Accepted
2023-02-15 16:11:10
Documents
1
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm236831-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm236831-4_4seq1.xml 4 6146
  Complete submission text file 0001104659-23-022388.txt   7660
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address
Jones Erika (Reporting) CIK: 0001895913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 23635463